Stocks
Themes
Market Cap Ranking
Trading Strategies
SEC Filings TLDR
Analysis Reports
Sign in
Loading stock data...
Loading updates and signals...
Back
NTLA
$13.12
-6.02%
Analyze
1M
-19.6%
3M
-3.5%
1Y
-17.7%
Market Cap:
$1.41B
Intellia Therapeutics Inc
Healthcare |
Biotechnology
Intellia Therapeutics, Inc., a genome editing company, is focused on developing therapies. The company is headquartered in Cambridge, Massachusetts.
Click "Analyze" to generate stock analysis
NTLA Price Trend and Signals
NTLA Option Volumes & Open Interests (aggregated)
NTLA Put Call Ratios and IV (aggregated)
NTLA Financials
Signals
News
SEC Filings
Holders
Research Reports
AI Analysis
2025-10-29
Somewhat Bearish
price_signal
Monthly low detected.
2025-10-28
Somewhat Bearish
price_signal
Monthly low detected.
2025-10-27
Neutral
volume_signal
Abnormal volume detected compared to 5-day moving average.
2025-10-27
Neutral
volume_signal
Abnormal volume detected compared to 10-day moving average.
2025-10-27
Neutral
volume_signal
Abnormal volume detected compared to 20-day moving average.
2025-10-27
Neutral
volume_signal
Abnormal volume detected compared to 3 mon moving average.
2025-10-27
Somewhat Bearish
price_signal
Monthly low detected.
2025-10-27
Bearish
price_signal
Large price change detected: -42.23%.
2025-10-27
Neutral
option_volume_signal
Abnormal option volume detected compared to 5-day moving average.
2025-10-27
Neutral
option_volume_signal
Abnormal option volume detected compared to 3 mon moving average.
2025-10-23
Somewhat Bearish
macd_signal
Dead cross above zero detected.
2025-10-20
Somewhat Bullish
price_signal
Yearly high detected.
2025-10-15
Somewhat Bullish
price_signal
Yearly high detected.
2025-10-09
Somewhat Bullish
price_signal
Yearly high detected.
2025-10-08
Neutral
option_volume_signal
Abnormal option volume detected compared to 3 mon moving average.